ICU(ICU)
ICU
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $2M | $3M | $16M |
| Low | $2M | $3M | $16M |
| High | $2M | $3M | $16M |
| EBITDA Avg | $390,799 | $586,199 | $3M |
| Low | $386,253 | $579,380 | $3M |
| High | $395,346 | $593,019 | $3M |
| EBIT Avg | $390,799 | $586,199 | $3M |
| Low | $386,253 | $579,380 | $3M |
| High | $395,346 | $593,019 | $3M |
| Net Income Avg | $-75M | $-48M | $-16M |
| Low | $-77M | $-49M | $-16M |
| High | $-74M | $-48M | $-16M |
| EPS Avg | $-3.64 | $-2.33 | $-0.76 |
| Low | $-3.70 | $-2.37 | $-0.77 |
| High | $-3.58 | $-2.30 | $-0.75 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $450,500 | $519,499 |
| Low | $427,038 | $492,444 |
| High | $473,961 | $546,553 |
| EBITDA Avg | $90,099 | $103,899 |
| Low | $85,407 | $98,488 |
| High | $94,792 | $109,310 |
| EBIT Avg | $90,099 | $103,899 |
| Low | $85,407 | $98,488 |
| High | $94,792 | $109,310 |
| Net Income Avg | $-35M | $-35M |
| Low | $-37M | $-37M |
| High | $-33M | $-33M |
| EPS Avg | $-0.90 | $-0.89 |
| Low | $-0.96 | $-0.95 |
| High | $-0.83 | $-0.83 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |